Retrieve available abstracts of 11 articles: HTML format
Single Articles
February 2025
CECCHINI M, Pilat MJ, Uboha N, Azad NS, et al Olaparib in treatment-refractory isocitrate dehydrogenase 1 (IDH1)- and
IDH2-mutant cholangiocarcinoma: Safety and antitumor activity from the phase 2
National Cancer Institute 10129 trial.
Cancer. 2025;131:e35755. PubMedAbstract available
TAN S, Feng M, Zhou N, Zhang S, et al DNA damage response and repair gene mutations predict clinical outcomes in
biliary tract cancer.
Cancer. 2025;131:e35726. PubMedAbstract available
June 2024
SAJ F, Wu YL, Pant S, Goyal L, et al Dual checkpoint inhibition in gallbladder cancer: Bridging new hope with the need
for biomarkers.
Cancer. 2024 Jun 14. doi: 10.1002/cncr.35352. PubMed
FONG ZV, Teinor J, Engineer L, Yeo TP, et al Caregiver-reported quality of communication in pancreatic and periampullary
cancer.
Cancer. 2024;130:2051-2059. PubMedAbstract available
March 2024
CHEUNG D, Stucky CC, Fong ZV The rise of biliary tract cancers and next-generation population registries.
Cancer. 2024 Mar 19. doi: 10.1002/cncr.35284. PubMed
February 2024
CHOI WJ, Roberts S, Verma A, Razak F, et al Characterizing the burden of biliary tract cancers across 28 hospitals in
Ontario, Canada.
Cancer. 2024 Feb 15. doi: 10.1002/cncr.35249. PubMedAbstract available
PATEL SP, Guadarrama E, Chae YK, Dennis MJ, et al SWOG 1609 cohort 48: anti-CTLA-4 and anti-PD-1 for advanced gallbladder cancer.
Cancer. 2024 Feb 15. doi: 10.1002/cncr.35243. PubMedAbstract available
July 2023
CAI QY, Yang P, Yang XL, Zhang XH, et al The association of carbohydrate antigen 19-9 response with radiologic response
and survival in intrahepatic cholangiocarcinoma: A prospective cohort study.
Cancer. 2023 Jul 14. doi: 10.1002/cncr.34854. PubMedAbstract available
May 2023
JANKU F, Javle MM, Sen S, Pant S, et al A phase 1/2a safety, pharmacokinetics, and efficacy study of the novel nucleoside
analog FF-10502-01 for the treatment of advanced solid tumors.
Cancer. 2023;129:1537-1546. PubMedAbstract available
March 2023
KEARNEY JF, Weighill D, Yeh JJ Promise of bile circulating tumor DNA in biliary tract cancers.
Cancer. 2023 Mar 18. doi: 10.1002/cncr.34715. PubMed
OHYAMA H, Hirotsu Y, Amemiya K, Miura Y, et al Comparison of genomic profiling of circulating tumor DNA in pancreaticobiliary
malignancies in plasma and bile.
Cancer. 2023 Mar 18. doi: 10.1002/cncr.34717. PubMedAbstract available